One Year Of Rheuma Tv

Today marks the one-year anniversary of Rheuma Tv’s launch. We are delighted to celebrate our anniversary with everyone. RheumaTv was launched to empower rheumatology specialists and physicians with a keen interest in rheumatology. It offers academic information for UG and PG students, clinically challenging case studies, journal reviews, quizzes, webinars, and expert talks by healthcare professionals and experts. We also have a rheumatology calculator where you can measure various rheumatological conditions. Several informational webinar series were conducted on various topics such as immunology & inflammation, investigations in rheumatology, tofacitinib in rheumatology, and Conventional DMARDs in rheumatoid arthritis. We thank our sponsors for their support.

The upcoming events include “Annual training program on biostatistics and research methodology workshop- 2022”, a webinar on the “use of biologics in rheumatology”, live case discussions, expert views & symposiums on various topics. Sign up/register with us to receive information on the various programs available on our website.

Most Viewed

Rheumatoid Arthrits

Is rheumatoid arthritis two different diseases?
Finally! a definition for difficult-to-treat rheumatoid arthritis
Guidelines for the treatment of rheumatoid arthritis
Are we going to have vaccine for rheumatoid arthritis?
Researchers identify mitochondrial proteins linked to T cell dysfunction in rheumatoid arthritis
Study validates the superiority of denosumab over bisphosphonates in managing rheumatoid arthritis
Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Cells from a cheek swab may serve as biomarkers for female rheumatoid arthritis
DMARDSs do not reduce the risk for Parkinson disease in rheumatoid arthritis patients
Lipidomics profiling may serve as a biomarker for disease evolution and activity in rheumatoid arthritis
Power Doppler ultrasound effective in predicting rheumatoid arthritis
DMARD combination/ monotherapy impairs the immunogenicity of inactivated SARS-CoV- 2 vaccine in rheumatoid arthritis
Should we vaccinate high risk rheumatic disease with third booster dose?
The effect of baricitinib in uncoupling the disease activity and structural damage progression in RA
American College of Rheumatology releases newer guidelines for the perioperative management of RA patients undergoing total knee arthroplasty
Behcet’s disease is linked to Multiple sclerosis and rheumatoid arthritis
Can IL 11 be the new potential target in RA with ILD?
Passive smoking can function as an elevated risk factor for RA in women
Computer Vision an effective tool for quantifying synovial inflammation in rheumatoid arthritis
Two-week methotrexate discontinuation helps to improve the SARS-CoV-2 vaccine efficacy in RA patients
Switching between JAK inhibitors could be beneficial in certain subset of RA patients
Concomitant administration of tacrolimus and biological DMARDS, a potential rescue therapy in rheumatoid arthritis
Prevalence of multimorbidities in RA patients
Impact of smoking and alcohol on rheumatic and musculoskeletal disease
Researchers propose suggestions to guide the safer use of methotrexate in RA patients
Early methotrexate treatment can modify the disease course of RA
Anti-SSA antibody positivity could be predictive of treatment response in RA patients
Tofacitinib treatment is better after conventional DMARDs in RA patients
ORAL Surveillance trial findings report increased infections in RA patients receiving tofacitinib
Olokizumab, a new drug for managing rheumatoid arthritis
Researchers identify sulfatase-2 as key protein that drives rheumatoid arthritis damage
Molecular signature-assisted drug selection helps in improving therapeutic response in RA
Unincreased hospitalization risk in elderly rheumatoid arthritis patients undergoing targeted therapy
Investigation in Rheumatology, Session – 2
Investigations in Rheumatology Series 4: Conventional Radiology in Rheumatology by Dr. URK RAO
Investigation in Rheumatology series-5
Investigations in Rheumatology Series – 6 (MRI in Rheumatology)
Cs DMARDS in Rheumatoid Arthritis,Lecture1 Introduction to DMARDs A concept to current understanding
Conventional DMARDS in Rheumatoid Arthritis , Lecture 2: Pre-evaluation for use of DMARDs
Lecture 3 Methotrexate:- Pharmacology, pharmacodynamics and mechanism
Conventional DMARDS in Rheumatoid Arthritis, Lecture 4 Clinical use of Methotrexate in Rheumatology
CS DMARDS in Rheumatoid Arthritis, Safety concern, precautions and management of adverse events
Lecture 6: CS DMARDs, Hydroxychloroquine :- Pharmacology, pharmacodynamics and mechanism
Lecture 7: CS DMARDs, Hydroxychloroquine, Clinical use in Rheumatology- Safety concern, Precautions and Management
CS DMARDS in Rheumatoid Arthritis: Leflunomide – Pharmacology, Pharmacodynamics and Mechanism
Leflunomide- Clinical use in rheumatology- SafetyConcern, Precautions & Management of Adverse Events
CS DMARDS in Rheumatoid Arthritis: Sulfasalazine – Pharmacology, Pharmacodynamics and Mechanism
Sulfasalazine Clinical use in Rheumatology Safety concern precautions & management of Adverse Events
CS DMARDS in Rheumatoid Arthritis: Iguratimod – Pharmacology, Pharmacodynamics and Mechanism
Iguratimod – Clinical use in rheumatology- Safety concern, precautions& management of adverse events
CS DMARDS in Rheumatoid Arthritis: Other DMARDs – Azathioprine,cyclosporine,D-penicillamine and Gold

Autoimmune disorders

Should we vaccinate high risk rheumatic disease with third booster dose?
Is rheumatoid arthritis two different diseases?
Guidelines for the treatment of rheumatoid arthritis
Are we going to have vaccine for rheumatoid arthritis?
Researchers identify mitochondrial proteins linked to T cell dysfunction in rheumatoid arthritis
Oral microbiome influences the risk of developing rheumatoid arthritis
Study validates the superiority of denosumab over bisphosphonates in managing rheumatoid arthritis
Researchers provide consensus recommendations on managing selected comorbidities in rheumatoid arthritis
Cells from a cheek swab may serve as biomarkers for female rheumatoid arthritis
Favorable benefit-risk ratio of upadacitinib compared to adalimumab for managing moderate-to severe RA
Second COVID vaccine improves the serological response in patients with autoimmune diseases
Human leukocyte antigen-B27 status is not suggestive of treatment response in psoriatic arthritis axial disease
DMARDSs do not reduce the risk for Parkinson disease in rheumatoid arthritis patients
Researchers validate the role of serum biomarkers in determining disease activity of ANCA-associated vasculitis
Researchers explore the pattern of uveitis in routine ophthalmology practice in India
Myositis specific antibodies to predict treatment response in idiopathic inflammatory myopathies
Metabolomic profiling in RA may help identifying patients prone to ILD
Etanercept tapering is feasible without compromising the efficacy in patients with autoimmune disease
Mood disorders and fibromyalgia impair the cognitive function in SLE patients
C‑reactive protein isoforms help to differentiate between SLE quiescent and active phenotypes
Can Iberodomide be a novel drug in SLE management?

DMARDS

error: Content is protected !!